Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with ...
A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...
FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback